Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206908 · ClinicalTrials.gov registry record
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 900
- Enrollment target
NCT00206908: Completed study, sponsored by Abbott RDx Cardiometabolic.
NCT00206908 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 900 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00206908 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 900 participants
- Enrollment target
Study Summary
This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentration of various analytes present in EDTA-anticoagulated whole blood or plasma, specifically B-type natriuretic peptide (BNP), fibrin degradation products containing D-Dimer, matrix metalloproteiase-9 (MMP-9), and S-100B. The test utilizes a proprietary algorithm for the automatic calculation of a single Multimarker Index (MMX) result from the individual biomarker values. The MMX result is being evaluated for use as an aid in the assessment and diagnosis of stroke.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2002-07 |
What the finished NCT00206908 record still lists
NCT00206908 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00206908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00206908 about?
NCT00206908 is a clinical study titled "BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)". This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentrati...
What is the current status of trial NCT00206908?
This trial is currently completed. The enrollment target is 900 participants. The study started on 2002-07.
Who is sponsoring clinical trial NCT00206908?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia